Quote | Chemomab Therapeutics Ltd. (NASDAQ:CMMB)
Last: | $0.7352 |
---|---|
Change Percent: | -0.06% |
Open: | $0.7258 |
Close: | $0.7352 |
High: | $0.7353 |
Low: | $0.667 |
Volume: | 12,160 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
News | Chemomab Therapeutics Ltd. (NASDAQ:CMMB)
TEL AVIV, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that Chief Executive Officer Dr. Adi Mor will de...
TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd . (Nasdaq: CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced the company will report its first quarte...
Message Board Posts | Chemomab Therapeutics Ltd. (NASDAQ:CMMB)
Subject | By | Source | When |
---|---|---|---|
short data if anyone is interested | Distantpulse | investorshub | 06/25/2023 1:08:37 PM |
Lol for real! | Distantpulse | investorshub | 06/22/2023 12:58:56 PM |
Its a dog with fleas! lol | subslover | investorshub | 06/22/2023 12:58:13 PM |
And it still crashes.smfh. | Distantpulse | investorshub | 06/22/2023 12:55:41 PM |
MomentumIts trading last trade up | crudeoil24 | investorshub | 06/21/2023 7:31:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Chemomab Therapeutics Ltd. Company Name:
CMMB Stock Symbol:
NASDAQ Market:
TEL AVIV, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB) (Chemomab), a clinical stage biotechnology company d...
TEL AVIV, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that Chief Executive Officer Dr. Adi Mor will de...
TEL AVIV, Israel, April 24, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (NASDAQ:CMMB), (Chemomab), a clinical stage biotechnology compan...